Business Trip

59 Episoder

1. Holy poop! Mental health and the gut (part 2 with Bloom Science)

   Publisert: 28.9.2023
2. Holy poop! Mental health and the gut (part 1 with Holobiome)

   Publisert: 14.9.2023
3. Ketamine for OCD: Carolyn Rodriguez (Stanford pt 3)

   Publisert: 24.8.2023
4. Are psychedelics effective under anesthesia?: Boris Heifets (Stanford pt 2)

   Publisert: 17.8.2023
5. The Startup Landscape for Expanding Consciousness

   Publisert: 9.8.2023
6. Stanford Psychedelic Overview: Robert Malenka (Stanford pt 1)

   Publisert: 20.7.2023
7. Live from Psychedelic Science 2023

   Publisert: 7.7.2023
8. What VCs Look for in Psychedelic Companies

   Publisert: 9.6.2023
9. Developing Non-Hallucinogenic Psychedelics: Bryan Roth

   Publisert: 15.5.2023
10. Behind the Scenes of PsyMed Ventures

    Publisert: 14.4.2023
11. The 2023 Psychedelic Industry Landscape with Psychedelic Alpha

    Publisert: 27.2.2023
12. The State of Psychedelics (Part 2): Dr. Rachel Yehuda and Zach Haigney (live recording at Soho House)

    Publisert: 18.1.2023
13. The quest to improve MDMA

    Publisert: 20.12.2022
14. Transcranial magnetic stimulation (TMS) paired with ketamine: inside a clinic offering a frontier treatment

    Publisert: 29.11.2022
15. Perspectives from Christian Angermayer, investor and founder in psychedelics

    Publisert: 27.10.2022
16. Soltara: an ethical and profitable ayahuasca retreat

    Publisert: 14.9.2022
17. Microdosing (part 3): The path to FDA approval w/ MindMed and Diamond Therapeutics

    Publisert: 16.8.2022
18. Microdosing (part 2): Placebo is a hell of a drug with Balázs Szigeti

    Publisert: 10.8.2022
19. Microdosing (part 1): James Fadiman and the fundamentals of microdosing

    Publisert: 3.8.2022
20. How the DEA and FDA will regulate psychedelic medicine

    Publisert: 24.6.2022